HHLR ADVISORS, LTD. reports

Company location: Grand Cayman, Cayman Islands
Fiscal year end: 31 December

HHLR ADVISORS, LTD. has filed 136 SEC EDGAR filings since 03 Jan 2019

Filter by type:
SC13D
SC13G

SEC filing history

Showing 101-125 of 136 matching filings.

Per page

25

Current page

5

SC 13D/A

CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.

Filing date: 18 Sep 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D

I-MAB

Filing date: 14 Sep 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-19395

13F-HR filing

Filing date: 14 Aug 2020
Reporting date: 30 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

BEIGENE, LTD.

Filing date: 14 Jul 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3 File 001-37686

3 filing

Filing date: 14 Jul 2020
Reporting date: 12 Jul 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

CELLULAR BIOMEDICINE GROUP, INC.

Filing date: 24 Jun 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-19395

13F-HR filing

Filing date: 15 May 2020
Reporting date: 31 Mar 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.

Filing date: 08 May 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

CELLULAR BIOMEDICINE GROUP, INC.

Filing date: 30 Mar 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

CELLULAR BIOMEDICINE GROUP, INC.

Filing date: 21 Feb 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

VIELA BIO, INC.

Filing date: 14 Feb 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

GOSSAMER BIO, INC.

Filing date: 14 Feb 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

APELLIS PHARMACEUTICALS, INC.

Filing date: 14 Feb 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

BILIBILI INC.

Filing date: 14 Feb 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

TAL EDUCATION GROUP

Filing date: 14 Feb 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MOGU INC.

Filing date: 14 Feb 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

KINIKSA PHARMACEUTICALS, LTD.

Filing date: 14 Feb 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

IQIYI, INC.

Filing date: 14 Feb 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-19395

13F-HR filing

Filing date: 14 Feb 2020
Reporting date: 31 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

CELLULAR BIOMEDICINE GROUP, INC.

Filing date: 30 Jan 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

SC 13D/A filing

Filing date: 27 Jan 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3 File 001-36498

3 filing

Filing date: 20 Nov 2019
Reporting date: 10 Nov 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-19395

13F-HR filing

Filing date: 14 Nov 2019
Reporting date: 30 Sep 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D

CELLULAR BIOMEDICINE GROUP, INC.

Filing date: 12 Nov 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D

CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.

Filing date: 19 Sep 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .